These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 608000)

  • 1. [Prognostical factors of breast neoplasms without metastasis. Synthesis by a multifactoral analysis].
    Lagarde C; Avril A; Dilhuydy MH; Durand M; Hugues A; Imbert J; Palangie F; Richaud P
    Bull Cancer; 1977; 64(4):505-24. PubMed ID: 608000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical prognostic factors in breast cancer. Retrospective study of 5609 cases].
    Garbay JR; Hacène K; Tubiana-Hulin M; Yacoub S; Rouëssé J
    Bull Cancer; 1994 Dec; 81(12):1078-84. PubMed ID: 7742596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour.
    Demicheli R; Bonadonna G; Hrushesky WJ; Retsky MW; Valagussa P
    Breast Cancer Res; 2004; 6(6):R689-96. PubMed ID: 15535851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic value of estrogen and progesterone receptors in the operable breast cancer: results of a uni- and multifactorial analysis].
    Chevallier B; Heintzman F; Asselain B; Dauce JP; Bastit P; Graic Y; Brunelle P; Basuyau JP; Comoz M
    Bull Cancer; 1988; 75(1):23-36. PubMed ID: 3359056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What are the prognostic factors in operable breast cancer without histologic axillary lymph node invasiveness. Results of an uni- and multifactorial analysis].
    Chevallier B; Heintzman F; Mosseri V; Graic Y; Bastit P; Dauce JP; Maisse P; Cauchois D; Cabanne JP; Asselain B
    Bull Cancer; 1989; 76(1):51-60. PubMed ID: 2713515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncertain benefit from surgery in patients with lung metastases from breast carcinoma.
    Planchard D; Soria JC; Michiels S; Grunenwald D; Validire P; Caliandro R; Girard P; Le Chevalier T
    Cancer; 2004 Jan; 100(1):28-35. PubMed ID: 14692021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
    Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of clinico-pathological factors in prognosis of breast cancer patients.
    Bhalla S; Chattree N
    Indian J Pathol Microbiol; 1990 Jul; 33(3):250-7. PubMed ID: 2092002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prognostic model that makes quantitative estimates of probability of relapse for breast cancer patients.
    De Laurentiis M; De Placido S; Bianco AR; Clark GM; Ravdin PM
    Clin Cancer Res; 1999 Dec; 5(12):4133-9. PubMed ID: 10632351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival impact of integrative cancer care in advanced metastatic breast cancer.
    Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
    Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting distant dissemination in patients with early breast cancer.
    Arriagada R; Rutqvist LE; Johansson H; Kramar A; Rotstein S
    Acta Oncol; 2008; 47(6):1113-21. PubMed ID: 18607866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
    Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
    Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer patients with 10 or more involved axillary lymph nodes treated by multimodality therapy: influence of clinical presentation on outcome.
    Geara FB; Nasr E; Tucker SL; Charafeddine M; Dabaja B; Eid T; Abbas J; Salem Z; Shamseddine A; Issa P; El Saghir N
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):364-9. PubMed ID: 17324529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival.
    Grabau D; Jensen MB; Rank F; Blichert-Toft M
    APMIS; 2007 Jul; 115(7):828-37. PubMed ID: 17614850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
    Reed W; Bøhler PJ; Sandstad B; Nesland JM
    Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.